A few notable health care deals along with M&A in the AI-adjacent and reshoring themes occurred in January. Read more here.

In addition to these major listings expected this year, 2025, several other high-profile IPOs are anticipated in the near ...

Biocon plans to list its biosimilars business by March 2026, targeting a double-digit market share in the U.S. with five new ...

The primary market is all set to take a breather as no new ... the months ahead," said Pantomath Capital Advisors Private Limited, Trusted Mid-Market Investment Bank. Chamunda Electricals IPO ...

The IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, February 5. Malpani Pipes IPO: The allotment for the Malpani Pipes IPO is expected to be finalized on Monday, February 3.

We recently published a list of 12 Best Young Stocks To Buy and Hold For 10 Years. In this article, we are going to take a ...

We recently published a list of 12 Best Young Stocks To Buy and Hold For 10 Years. In this article, we are going to take a ...

Karman's listing comes at a time the U.S. IPO market is looking to recover from ... more than 10% of total sales during the ...

The company's business prospects have come under a cloud in recent ... the IPO yet, a separate person said. The FCA declined to comment. Market experts say it usually takes several months to ...

By Rishika Sadam HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its ...

Major investments in production expansion have been announced by Balady and Tanmiah Food, as Entaj prepares to list on the ...